Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009444
Filing Date
2019-10-30
Accepted
2019-10-30 16:20:58
Documents
80
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vstm-20190930x10q.htm 10-Q 1837753
2 EX-10.1 vstm-20190930ex1018e984c.htm EX-10.1 982037
3 EX-31.1 vstm-20190930ex3110c24aa.htm EX-31.1 16378
4 EX-31.2 vstm-20190930ex312670add.htm EX-31.2 16666
5 EX-32.1 vstm-20190930ex3213fa0d3.htm EX-32.1 8553
6 EX-32.2 vstm-20190930ex3227c86c4.htm EX-32.2 8823
7 GRAPHIC vstm20190930ex1018e984c001.jpg GRAPHIC 36514
  Complete submission text file 0001558370-19-009444.txt   8646615

Data Files

Seq Description Document Type Size
8 EX-101.INS vstm-20190930.xml EX-101.INS 1654266
9 EX-101.SCH vstm-20190930.xsd EX-101.SCH 57389
10 EX-101.CAL vstm-20190930_cal.xml EX-101.CAL 67440
11 EX-101.DEF vstm-20190930_def.xml EX-101.DEF 221111
12 EX-101.LAB vstm-20190930_lab.xml EX-101.LAB 551804
13 EX-101.PRE vstm-20190930_pre.xml EX-101.PRE 391333
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 191180476
SIC: 2834 Pharmaceutical Preparations